Combining avelumab and stereotactic ablative body radiotherapy in metastatic castration-resistant pr...
Combining avelumab and stereotactic ablative body radiotherapy in metastatic castration-resistant prostate cancer : Efficacy and safety-phase II ICE-PAC
About this item
Full title
Combining avelumab and stereotactic ablative body radiotherapy in metastatic castration-resistant prostate cancer : Efficacy and safety-phase II ICE-PAC
Author / Creator
Publisher
Germany
Journal title
Urologe. Ausgabe A, 2022-03, Vol.61 (3), p.301-303
Language
German
Formats
Publication information
Publisher
Germany
Subjects
More information
Alternative Titles
Full title
Combining avelumab and stereotactic ablative body radiotherapy in metastatic castration-resistant prostate cancer : Efficacy and safety-phase II ICE-PAC
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2611661252
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2611661252
Other Identifiers
E-ISSN
1433-0563
DOI
10.1007/s00120-021-01743-x
